Affinium Pharmaceuticals, Ltd. Announces the Initiation of a Phase I ClinicalTrial Using an Oral Formulation of AFN-1252
15-Apr-2010
- USA
Most read news
Organizations
Affinium Pharmaceuticals
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.